Chemical news · Three minutes a day

Daily Morning Brief

Tuesday, September 8, 2026

Today's Top Stories

  1. 02

    The European Investment Bank granted Elia a €1 billion loan for its Princess Elisabeth energy island project in the North Sea. Connecting offshore wind farms to the Belgian grid, this marks the largest EIB energy infrastructure loan in the Benelux region.

  2. 03

    Uganda appointed Vitol to market its crude oil exports, delaying commercial production to early 2027 due to infrastructure delays. The deal expands Vitol's regional presence alongside partners TotalEnergies and CNOOC in the Pearl Sweet project.

  3. 04

    Adnoc is negotiating stakes in Thailand’s PTT and Nigeria’s Dangote refineries to secure crude buyers and expand fuel trading. This strategic shift aims to bolster the UAE company’s downstream presence amid regional supply disruptions.

  4. 05

    ISS advised Conagra Brands shareholders to reject executive pay changes due to poor financial performance and unclear targets. The food company recently halved its dividend and is reviewing assets under new CEO John Brase.

  5. 06

    Australia's Santos acquired an additional 3.3% stake in the Papua LNG project from TotalEnergies for $189 million, raising its total interest to 21%. The deal is expected to boost equity LNG production by about 19% pending a final investment decision in 2026.

  1. 07

    According to BNEF, China tightened PV production regulations to address overcapacity and stabilize prices with new efficiency and quality standards. CATL also forecasts new energy heavy-duty truck penetration will reach 50% by 2028.

  2. 08

    Mercuria and Gunvor reported profit surges exceeding 100% and 600% respectively, driven by Middle East geopolitical tensions disrupting global energy and metal trade flows.

  3. 09

    Iraq's state oil marketer SOMO struggles to sell Basra crude after cutting discounts, as high shipping costs and Strait of Hormuz risks deter traders. Buyers remain hesitant despite Baghdad's revenue needs, highlighting regional supply chain friction.

  4. 10

    Novo Nordisk reported that 40.4% of children aged 6 to under 12 treated with semaglutide were no longer classified as obese after 68 weeks in the STEP Young trial. Safety profiles remained consistent with adult data while showing superior BMI reduction versus placebo.

Past Issues

Daily Morning Brief · Tuesday, September 8, 2026 — ChemBrief Topics